Browsing by Author "Swift, Shannon"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors
    (Oxford University Press, 2022) Mullenix, Cristina; Ballman, Madison; Chen, Haobin; Swift, Shannon; McAdams, Meredith J.; Tsai, Yo-Ting; Donahue, Renee N.; Poretta, Trina; Gupta, Sarthak; Loehrer, Patrick J.; Schlom, Jeffrey; Gulley, James L.; Rajan, Arun; Medicine, School of Medicine
    Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers. However, activation of the immune system can occasionally cause life-threatening toxicity involving critical organs. Induction of immune-mediated toxicity is a significant concern for patients with thymic epithelial tumors (TETs) due to defects in immune tolerance. An increased risk of skeletal and cardiac muscle inflammation following treatment with ICIs is well recognized in patients with advanced TETs. However, uncommon musculoskeletal and rheumatic complications can also occur. The cases presented in this report highlight the spectrum of presentation of immune-mediated, joint-predominant musculoskeletal adverse events in patients with advanced TETs treated with ICIs, including polymyalgia rheumatica-like illness and inflammatory arthritis.